Abrams Darryl, Javidfar Jeffrey, Farrand Erica, Mongero Linda B, Agerstrand Cara L, Ryan Patrick, Zemmel David, Galuskin Keri, Morrone Theresa M, Boerem Paul, Bacchetta Matthew, Brodie Daniel
Crit Care. 2014 Feb 27;18(1):R38. doi: 10.1186/cc13746.
Critical illness is a well-recognized cause of neuromuscular weakness and impaired physical functioning. Physical therapy (PT) has been demonstrated to be safe and effective for critically ill patients. The impact of such an intervention on patients receiving extracorporeal membrane oxygenation (ECMO) has not been well characterized. We describe the feasibility and impact of active PT on ECMO patients.
We performed a retrospective cohort study of 100 consecutive patients receiving ECMO in the medical intensive care unit of a university hospital.
Of the 100 patients receiving ECMO, 35 (35%) participated in active PT; 19 as bridge to transplant and 16 as bridge to recovery. Duration of ECMO was 14.3 ± 10.9 days. Patients received 7.2 ± 6.5 PT sessions while on ECMO. During PT sessions, 18 patients (51%) ambulated (median distance 175 feet, range 4 to 2,800) and 9 patients were on vasopressors. Whilst receiving ECMO, 23 patients were liberated from invasive mechanical ventilation. Of the 16 bridge to recovery patients, 14 (88%) survived to discharge; 10 bridge to transplant patients (53%) survived to transplantation, with 9 (90%) surviving to discharge. Of the 23 survivors, 13 (57%) went directly home, 8 (35%) went to acute rehabilitation, and 2 (9%) went to subacute rehabilitation. There were no PT-related complications.
Active PT, including ambulation, can be achieved safely and reliably in ECMO patients when an experienced, multidisciplinary team is utilized. More research is needed to define the barriers to PT and the impact on survival and long-term functional, neurocognitive outcomes in this population.
危重病是公认的神经肌肉无力和身体功能受损的原因。物理治疗(PT)已被证明对危重病患者是安全有效的。这种干预措施对接受体外膜肺氧合(ECMO)的患者的影响尚未得到充分描述。我们描述了主动物理治疗对ECMO患者的可行性和影响。
我们对一家大学医院医学重症监护病房连续接受ECMO治疗的100例患者进行了回顾性队列研究。
在100例接受ECMO治疗的患者中,35例(35%)参与了主动物理治疗;19例作为移植过渡,16例作为康复过渡。ECMO持续时间为14.3±10.9天。患者在接受ECMO治疗期间接受了7.2±6.5次物理治疗。在物理治疗期间,18例患者(51%)能够行走(中位距离175英尺,范围4至2800英尺),9例患者使用血管升压药。在接受ECMO治疗期间,23例患者脱离了有创机械通气。在16例康复过渡患者中,14例(88%)存活至出院;10例移植过渡患者(53%)存活至移植,其中9例(90%)存活至出院。在23例幸存者中,13例(57%)直接回家,8例(35%)前往急性康复机构,2例(9%)前往亚急性康复机构。没有与物理治疗相关的并发症。
当使用经验丰富的多学科团队时,在ECMO患者中可以安全可靠地实现包括行走在内的主动物理治疗。需要更多的研究来确定物理治疗的障碍以及对该人群生存和长期功能、神经认知结果的影响。